GlaxoSmithKline Pharmaceuticals Limited Financial Overview
GlaxoSmithKline Pharmaceuticals Limited's market cap is currently ₹438.49B. The company's EPS TTM is ₹15; its P/E ratio is 45.90; and it has a dividend yield of 2.09%. GlaxoSmithKline Pharmaceuticals Limited is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
